Earnings Feed
Start Free
Zoetis Inc.·4

Feb 19, 8:53 PM ET

Lagano Roxanne 4

4 · Zoetis Inc. · Filed Feb 19, 2026

Research Summary

AI-generated summary of this filing

Updated

Zoetis (ZTS) EVP Roxanne Lagano Receives 18,163 RSU Award

What Happened
Roxanne Lagano, Executive Vice President of Zoetis Inc. (ZTS), was granted two RSU awards on February 18, 2026: 3,664 RSUs and 14,499 RSUs, for a total of 18,163 RSUs. The grants were recorded at $0.00 (i.e., awards/compensation rather than a purchase) and are reported as derivative securities (RSUs represent a contingent right to receive one share each upon vesting).

Key Details

  • Transaction date: February 18, 2026; Form 4 filed February 19, 2026 (timely — Form 4s are generally due within two business days).
  • Grant amounts: 3,664 RSUs and 14,499 RSUs (total 18,163 RSUs). Reported acquisition price: $0.00 (award).
  • Vesting: Per the filing footnotes, each RSU represents a contingent right to one share and vests one-third on the first, second and third anniversaries of the grant date (grant date: Feb 18, 2026) — i.e., a three-year annual vesting schedule. Dividend-equivalent units are automatically issued on the RSUs. (See footnotes F1–F3.)
  • Shares owned after transaction: Not specified in the provided data.
  • No sale or cashless exercise reported; these were compensation awards, not purchases or disposals.
  • No tax-withholding sale or 10b5-1 plan referenced for these grants in the provided notes.

Context
RSU grants are a standard form of long-term compensation and are derivative awards that convert into ordinary shares only as they vest; they do not represent an immediate market purchase or sale. For retail investors, grants can indicate how the company compensates executives but are not direct bullish or bearish signals about near-term insider market activity.

Insider Transaction Report

Form 4
Period: 2026-02-18
Zoetis Inc.ZTS
Lagano Roxanne
Executive Vice President
Transactions
  • Award

    Restricted Stock Unit

    [F1][F2][F3][F4]
    2026-02-18+3,664→ 3,664 total
    → Common Stock (3,664 underlying)
  • Award

    Stock Option

    [F7][F8][F9]
    2026-02-18+14,499→ 14,499 total
    Exercise: $129.13→ Common Stock (14,499 underlying)
Holdings

  • Restricted Stock Unit

    [F1][F2][F5][F4]
    → Common Stock (2,250.426 underlying)
    2,250.426

  • Restricted Stock Unit

    [F1][F2][F6][F4]
    → Common Stock (545 underlying)
    545

  • Stock Option

    [F7][F10][F9]
    Exercise: $156.64→ Common Stock (8,642 underlying)
    8,642

  • Stock Option

    [F7][F11][F9]
    Exercise: $196.14→ Common Stock (6,127 underlying)
    6,127

  • Stock Option

    [F7][F12][F9]
    Exercise: $162.07→ Common Stock (6,542 underlying)
    6,542

  • Stock Option

    [F13][F14][F15][F9]
    → Common Stock (20,221 underlying)
    20,221
Footnotes (15)
  • [F1]Represents restricted stock units granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan, and dividend equivalent units automatically issued thereon (each an "RSU" and collectively, "RSUs").
  • [F10]One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 19, 2025.
  • [F11]One-third of each option vests on the first, second and third anniversaries of the date of grant, February 6, 2024.
  • [F12]One-third of each option vested on the first, second and third anniversaries of the date of grant, February 8, 2023.
  • [F13]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan.
  • [F14]7,738 options granted February 11, 2020 at an exercise price of $144.03 per option; 7,106 options granted February 10, 2021 at an exercise price of $160.62 per option; and 5,377 options granted February 8, 2022 at an exercise price of $201.30 per option.
  • [F15]Each option vested on the third anniversary of the date of grant.
  • [F2]Each RSU represents a contingent right to receive one share of Zoetis Inc. common stock.
  • [F3]One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 18, 2026; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  • [F4]Not applicable.
  • [F5]One-third of each RSU will vest and be settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 19, 2025; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  • [F6]One-third of each RSU vests and is settled in shares of Zoetis Inc. common stock on the first, second and third anniversaries of the date of grant, February 6, 2024; subject to the reporting person's continued service through such vesting date and subject to earlier vesting and settlement upon certain specific events.
  • [F7]Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. Amended and Restated 2013 Equity and Incentive Plan.
  • [F8]One-third of each option will vest on the first, second and third anniversaries of the date of grant, February 18, 2026.
  • [F9]Each option expires on the tenth anniversary of the date of grant.
Signature
/s/ Brenda Santuccio, as Attorney-in-Fact|2026-02-19

Documents

1 file
  • 4
    wk-form4_1771552374.xmlPrimary

    FORM 4